Impax to Present at Bank Of America Specialty Pharmaceuticals Conference

July 31, 2008

HAYWARD, Calif.(July 31, 2008) – IMPAX Laboratories, Inc. today announced that Arthur A. Koch, Jr., its senior vice president and chief financial officer, will present at the Bank of America 2008 Specialty Pharmaceuticals Conference on Thursday, August 7th, at 9:30 a.m. Eastern time.  The conference will be held at the Southampton Inn, Long Island, New York from August 7 to 8, 2008.  Individuals may listen to the live or an archived presentation made at the conference, which will be posted in the investor relations section of the Company’s web site at .  To listen to the live presentation, please go to the web site 15 minutes prior to its start to register, download, and install the necessary audio software. This presentation will be archived on the Company’s web site for 90 days. The Company’s regular corporate presentation will be updated and posted on the Company’s web site on that date as well.

About IMPAX Laboratories, Inc.
IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. IMPAX markets its generic products through its Global Pharmaceuticals division and markets its branded products through the IMPAX Pharmaceuticals division. Additionally, where strategically appropriate, IMPAX has developed marketing partnerships to fully leverage its technology platform. IMPAX Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company's Web site at:

Company Contacts: Investor Relations Contacts:

IMPAX Laboratories, Inc.                                          Lippert/Heilshorn & Associates, Inc.

Larry Hsu, Ph.D. President & CEO                         Kim Sutton Golodetz
(510) 476-2000, Ext. 1111                                       (
Arthur A. Koch, Jr., Sr. VP & CFO                           (212) 838-3777
(215) 933-0351                                                        Bruce Voss (
Mark Donohue, Sr. Director IR                                (310) 691-7100
(215) 933-3526